3/24/2025Elevation Oncology to Discontinue Development of CSPC-licensed EO-3021

3/24/2025HBM Enters into Global Strategic Deal with AstraZeneca for Next-Gen Th...

3/24/2025AstraZeneca Announces $2.5B Investment in China

3/24/2025Syneron Bio Announces Strategic Collaboration with AstraZeneca

3/24/2025GenScript's RA Drug Candidate Receives FDA Clearance for Clinical Tria...

3/24/2025SineuGene's SNUG01 Gene Therapy Receives FDA IND Approval for ALS Clin...

3/24/2025FDA Rejects HLB Group's Liver Cancer Drug, Highlighting Regulatory and...

3/24/2025CDE Seeks Public Comments on Draft ICH M11 Clinical Protocol Template

3/24/2025China Sets Ambitious Nutritional Targets for 2030 to Improve National ...

3/24/2025Heng Ren Partners Calls for $8.9B Cash Distribution from Sinovac and ...

3/21/2025Forward Pharma Secures CNY 100M Financing

3/21/2025Innovent and Hutchmed's FRUSICA-2 Study Achieves Primary Endpoint

3/21/2025Dizal's Golidocitinib in Combo with Anti-PD-1 Shows Promise in IO Resi...

3/21/2025Rhythm Pharma Regains Rights to Obesity Drug in China

3/21/2025Henlius' HER2-Targeting Antibody HLX22 Granted FDA Orphan Drug Designa...

3/21/2025CDE Solicits Comments on Chinese Translation of ICH E6 (R3) GCP Guidel...

3/21/2025Hengrui's Ivarmacitinib Secures First Approval in China for Ankylosing...

3/21/2025NHC Vice-Minister Meets with CEO of Belgian Biopharma Firm UCB

3/21/2025NHSA Releases Its 2024 Statistical Bulletin on Healthcare Security De...

3/21/2025Gilead's Trodelvy Receives Second Approval in China

3/21/2025AZ's Calquence (Acalabrutinib) Receives New Approval in China for Firs...

3/21/2025Huadong Medicine's HDM1002 Advances to Phase III Clinical Trials

3/21/2025Junshi's Toripalimab Receives 11th Approval in China

3/21/2025NMPA Approves Hutchmed's Tazverik for r/r Follicular Lymphoma in China

3/21/2025Recent Executive Moves

3/21/2025Visen Pharma Debuts on Hong Kong Stock Exchange

3/20/2025Grand Pharma Advances Phase III Trial of ITM-11 in China

3/20/2025NMPA Seeks Public Feedback on Draft Guidelines for Drug Trial Data Pro...

3/20/2025CDE Publicizes the List of Reference Formulations for GQCE Studies (92...

3/20/2025Chinese Government Issues Notice on Strengthening Drug Traceability Co...

Page:5/761 Total number of articles:22823: [First][<<] [3] [4] [5] [6] [7] [>>] [End]